Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Active not recruiting 6Recruiting 5Not yet recruiting 4Completed 4Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Neoplasms 1

Interventions

Specimen Handling 76Cisplatin 64Drug Therapy 63Carboplatin 63Bevacizumab 63Magnetic Resonance Spectroscopy 59Radiotherapy 57Gemcitabine 54Cyclophosphamide 54pembrolizumab 52Oxaliplatin 49Capecitabine 49toripalimab 44Paclitaxel 40tislelizumab 39Standard of Care 39fludarabine 36Injections 34Fluorouracil 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 28Nivolumab 28Surgical Procedures, Operative 27Irinotecan 27Docetaxel 27Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × CP protocol × 1 year × Clear all
NCT07610525 2026-05-28

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07102940 2026-02-20

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

George Washington University

Phase 2 Not yet recruiting
50 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT07401654 2026-02-10

The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
60 enrolled
Gynecologic

Ovarian Neoplasms

NCT07107217 2025-08-17

Camella

Blokhin's Russian Cancer Research Center

Phase 2 Not yet recruiting
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡